We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$4.45B
AUM Growth
+$192M
Cap. Flow
+$102M
Cap. Flow %
2.31%
Top 10 Hldgs %
37.03%
Holding
3,677
New
275
Increased
1,530
Reduced
994
Closed
157

Sector Composition

Rank Sector Weight
1 Technology 16.97%
2 Healthcare 8.95%
3 Financials 7.08%
4 Communication Services 5.16%
5 Consumer Discretionary 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
26
Visa
V
$677B
$24.6M 0.55%
77,744
+2,117
+3% +$637K
QQQ icon
27
Invesco QQQ Trust
QQQ
$484B
$23.6M 0.53%
46,090
+559
+1% +$283K
NFLX icon
28
Netflix
NFLX
$309B
$22.9M 0.52%
256,930
+6,450
+3% +$531K
VTV icon
29
Vanguard Morningstar Value ETF
VTV
$191B
$22.5M 0.51%
132,907
+6,421
+5% +$1.13M
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$22.4M 0.5%
38,232
+2,832
+8% +$1.67M
CRM icon
31
Salesforce
CRM
$158B
$22.4M 0.5%
66,934
+237
+0.4% +$75.6K
IXN icon
32
iShares Global Tech ETF
IXN
$8.83B
$22.3M 0.5%
262,747
+5,325
+2% +$447K
MA icon
33
Mastercard
MA
$493B
$22.2M 0.5%
42,178
+837
+2% +$433K
VEA icon
34
Vanguard FTSE Developed Markets ETF
VEA
$236B
$21.6M 0.49%
451,162
-9,682
-2% -$486K
IGEB icon
35
iShares Investment Grade Systematic Bond ETF
IGEB
$1.46B
$21.4M 0.48%
481,882
+36,825
+8% +$1.67M
ISRG icon
36
Intuitive Surgical
ISRG
$134B
$21M 0.47%
40,283
+3,914
+11% +$2.04M
ACN icon
37
Accenture
ACN
$108B
$21M 0.47%
59,584
+371
+0.6% +$134K
LLY icon
38
Eli Lilly
LLY
$1.06T
$20.3M 0.46%
26,277
+2,628
+11% +$2.18M
VOO icon
39
Vanguard S&P 500 ETF
VOO
$1.01T
$20M 0.45%
37,044
+934
+3% +$506K
SPTM icon
40
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
$19.2M 0.43%
269,476
+12,474
+5% +$898K
ABBV icon
41
AbbVie
ABBV
$435B
$19.2M 0.43%
108,185
-620
-0.6% -$114K
VCIT icon
42
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.3B
$19M 0.43%
236,172
+8,444
+4% +$689K
IEMG icon
43
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
$18.6M 0.42%
356,421
+7,806
+2% +$432K
UNH icon
44
UnitedHealth
UNH
$370B
$17.5M 0.39%
34,536
-2,102
-6% -$1.19M
TMO icon
45
Thermo Fisher Scientific
TMO
$220B
$17.3M 0.39%
33,344
+8
+0% +$4.4K
AVGO icon
46
Broadcom
AVGO
$2.04T
$17.1M 0.39%
73,876
+3,038
+4% +$562K
SCHD icon
47
Schwab US Dividend Equity ETF
SCHD
$105B
$17.1M 0.38%
625,235
-37,672
-6% -$1.07M
CCI icon
48
Crown Castle
CCI
$32.2B
$16.7M 0.38%
183,965
+179,281
+3,828% +$18.7M
EFA icon
49
iShares MSCI EAFE ETF
EFA
$80.2B
$16.3M 0.37%
215,082
+3,243
+2% +$257K
INTU icon
50
Intuit
INTU
$89B
$16.2M 0.36%
25,803
+2,429
+10% +$1.55M

Similar funds

Parallel Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Parallel Advisors held 3,677 positions worth $4.45B, up 4.5% from $4.25B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2024 filing shows 275 new, 1,530 increased, 994 reduced and 157 closed positions. Its largest new stake was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M. The largest sale was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, an estimated $8.95M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Parallel Advisors's largest Q4 2024 buy was PIMCO Ultra Short Government Active ETF: 67,253 shares worth $6.78M.
  • Parallel Advisors added most to Crown Castle in Q4 2024, an estimated $18.7M increase.
  • Parallel Advisors's biggest Q4 2024 reduction was State Street SPDR Bloomberg 3-12 Month T-Bill ETF, cutting an estimated $8.95M.
  • Parallel Advisors fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $3.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.45B portfolio in Q4 2024.
  • Parallel Advisors opened 275 new positions and closed 157 in Q4 2024.
  • Parallel Advisors's portfolio value rose 4.5% quarter-over-quarter to $4.45B.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.